198 related articles for article (PubMed ID: 25484103)
1. RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner.
Wezel A; van der Velden D; Maassen JM; Lagraauw HM; de Vries MR; Karper JC; Kuiper J; Bot I; Quax PH
Atherosclerosis; 2015 Jan; 238(1):132-9. PubMed ID: 25484103
[TBL] [Abstract][Full Text] [Related]
2. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
[TBL] [Abstract][Full Text] [Related]
3. CD8+ T Cells Regulate Monopoiesis and Circulating Ly6C-high Monocyte Levels in Atherosclerosis in Mice.
Cochain C; Koch M; Chaudhari SM; Busch M; Pelisek J; Boon L; Zernecke A
Circ Res; 2015 Jul; 117(3):244-53. PubMed ID: 25991812
[TBL] [Abstract][Full Text] [Related]
4. Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice.
Babaev VR; Hebron KE; Wiese CB; Toth CL; Ding L; Zhang Y; May JM; Fazio S; Vickers KC; Linton MF
J Lipid Res; 2014 Nov; 55(11):2296-308. PubMed ID: 25240046
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of the TLR4 analogue RP105 aggravates vein graft disease by inducing a pro-inflammatory response.
Wezel A; de Vries MR; Maassen JM; Kip P; Peters EA; Karper JC; Kuiper J; Bot I; Quax PHA
Sci Rep; 2016 Apr; 6():24248. PubMed ID: 27053419
[TBL] [Abstract][Full Text] [Related]
7. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
[TBL] [Abstract][Full Text] [Related]
8. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
[TBL] [Abstract][Full Text] [Related]
9. New therapy via targeting androgen receptor in monocytes/macrophages to battle atherosclerosis.
Huang CK; Pang H; Wang L; Niu Y; Luo J; Chang E; Sparks JD; Lee SO; Chang C
Hypertension; 2014 Jun; 63(6):1345-53. PubMed ID: 24688120
[TBL] [Abstract][Full Text] [Related]
10. CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice.
Manthey HD; Cochain C; Barnsteiner S; Karshovska E; Pelisek J; Koch M; Chaudhari SM; Busch M; Eckstein HH; Weber C; Koenen RR; Zernecke A
Thromb Haemost; 2013 Dec; 110(6):1267-77. PubMed ID: 24114205
[TBL] [Abstract][Full Text] [Related]
11. Loss of
Babaev VR; Huang J; Ding L; Zhang Y; May JM; Linton MF
Front Immunol; 2018; 9():215. PubMed ID: 29487597
[TBL] [Abstract][Full Text] [Related]
12. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
[TBL] [Abstract][Full Text] [Related]
13. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
14. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis.
Keul P; Lucke S; von Wnuck Lipinski K; Bode C; Gräler M; Heusch G; Levkau B
Circ Res; 2011 Feb; 108(3):314-23. PubMed ID: 21164103
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes.
Babaev VR; Runner RP; Fan D; Ding L; Zhang Y; Tao H; Erbay E; Görgün CZ; Fazio S; Hotamisligil GS; Linton MF
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1283-90. PubMed ID: 21474828
[TBL] [Abstract][Full Text] [Related]
16. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
[TBL] [Abstract][Full Text] [Related]
17. Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
van Es T; van Puijvelde GH; Ramos OH; Segers FM; Joosten LA; van den Berg WB; Michon IM; de Vos P; van Berkel TJ; Kuiper J
Biochem Biophys Res Commun; 2009 Oct; 388(2):261-5. PubMed ID: 19660432
[TBL] [Abstract][Full Text] [Related]
18. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
[TBL] [Abstract][Full Text] [Related]
19. TLR4 accessory molecule RP105 (CD180) regulates monocyte-driven arteriogenesis in a murine hind limb ischemia model.
Bastiaansen AJ; Karper JC; Wezel A; de Boer HC; Welten SM; de Jong RC; Peters EA; de Vries MR; van Oeveren-Rietdijk AM; van Zonneveld AJ; Hamming JF; Nossent AY; Quax PH
PLoS One; 2014; 9(6):e99882. PubMed ID: 24945347
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2-/- mice: evidence for independent chemokine functions in atherogenesis.
Saederup N; Chan L; Lira SA; Charo IF
Circulation; 2008 Apr; 117(13):1642-8. PubMed ID: 18165355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
